Lantheus Holdings holds 7.7% · −2.3pp on the report before
Filed 09/23
StocksWho bought more than 5%?7.7% Is Wall Street adding or cutting?−6
All tracked funds
All 5% stake reports on Perspective Therapeutics
Perspective Therapeutics CATX
What to see in Perspective Therapeutics now
130 13F filers hold it · −6 against the quarter before · shares held +5.5%
Holdings of 06/30
Company
- Exchange
- NYSE
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Seattle, Washington
- Fiscal year end
- 12/31
- Next earnings
- 09/21, estimated
- Lantheus Holdings holds 7.7% · −2.3pp on the report beforeFiled 09/23
- 130 13F filers hold it · −6 against the quarter before · shares held +5.5%Holdings of 06/30
Funds
13F filers: 130 · −6 since the quarter before · 06/30 holdings
Famous funds that held Perspective Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsPerspective Therapeutics CATX · 06/30 holdings | $208.4K | No quarter before |
5% stakes
| Holder | ||
|---|---|---|
| Lantheus Holdings09/23 | 7.7%8,739,011 sh | −2.3pp |
| Lantheus Holdings09/04 | 10%11,440,513 sh | No earlier report |
| State Street08/07 | 5.3%6,051,771 sh | First report |
| BlackRock07/29 | 6.8%7,776,940 sh | +2.2pp |
| Millennium Management07/20 | 5.3%6,036,999 sh | +1.0pp |
| Millennium Management06/30 | 4.3%4,893,883 sh | First report |
| Stanley Morgan05/12 | 2.6%2,959,296 sh | −3.4pp |
| Avidity Partners Management03/10 | 5.3%6,049,999 sh | +1.1pp |
| Stanley Morgan02/12 | 6%4,461,893 sh | First report |
| Commodore Capital02/09 | 9.9%11,939,753 sh | First report |
| TCG Crossover GP II02/06 | 6.9%7,915,567 sh | First report |
| Investment Authority Qatar02/05 | 6.2%7,073,308 sh | First report |
| FMR25/12/05 | 0.4%312,164 sh | −7.8pp |
